SMi Source Lesson Anticoagulation: Standard Anticoagulants

  • SMi Source lesson Anticoagulation: Standard Anticoagulants has the following microlearning topics

  • 1. Introduction

    2. Anticoagulation Therapy Indications

    3. Atrial Fibrillation (AF): Stroke Risk

    4. Atrial Fibrillation (AF): Guidelines for Anticoagulation Therapy

    5. Venous Thromboembolism (VTE): Treatment Guideline Overview

    6. Venous Thromboembolism (VTE): Uncomplicated Treatment

    7. Complicated Venous Thromboembolism (VTE) Treatment

    8. Venous Thromboembolism (VTE)

    9. Venous Thromboembolism (VTE) Treatment Follow-Up and Secondary Prevention: Bridging and Perioperative Management

    10. Standard Anticoagulants

    11. Vitamin K Antagonists (VKAs)

    12. Unfractionated Heparin (UFH)

    13. Low Molecular Weight Heparin (LMWH)

    14. Low Molecular Weight Heparin (LMWH): Indications

    15. Fondaparinux

    16. Aspirin

    17. Selected Clinical Studies

    18. Vitamin K Antagonists (VKAs): Warfarin

    19. Vitamin K Antagonists (VKAs): Warfarin

    20. Unfractionated Heparin (UFH) and Low Molecular Weight Heparins (LMWHs)

    21. Fondaparinux: Treatment of Deep Vein Thrombosis

    22. Fondaparinux: Treatment of Pulmonary Embolism

    23. Aspirin: Stroke Prevention in Atrial Fibrillation (AF)

    24. Therapeutic Challenges of Antithrombotic Treatment

    25. Vitamin K Antagonists (VKAs): Warfarin

    26. Warfarin: Monitoring and Anticoagulant Reversal

    27. Unfractionated Heparin (UFH)

    28. Low Molecular Weight Heparin (LMWH): Boxed Warning

    29. Low Molecular Weight Heparin (LMWH): Enoxaparin and Dalteparin

    30. Fondaparinux: Boxed Warning, Laboratory Monitoring, and Anticoagulant Reversal

    31. Aspirin: Warnings and Anticoagulant Reversal

    32. Table of Agents